Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.33 - $5.68 $58,711 - $100,144
17,631 Added 23.31%
93,275 $324,000
Q1 2024

May 15, 2024

BUY
$5.39 - $7.29 $43,923 - $59,406
8,149 Added 12.07%
75,644 $482,000
Q4 2023

Feb 14, 2024

BUY
$2.13 - $6.63 $113,961 - $354,724
53,503 Added 382.38%
67,495 $434,000
Q3 2023

Nov 14, 2023

SELL
$2.32 - $3.36 $21,513 - $31,157
-9,273 Reduced 39.86%
13,992 $32,000
Q2 2023

Aug 14, 2023

SELL
$1.64 - $3.21 $119,082 - $233,081
-72,611 Reduced 75.73%
23,265 $55,000
Q1 2023

May 15, 2023

BUY
$1.75 - $2.25 $167,783 - $215,721
95,876 New
95,876 $176,000
Q3 2022

Nov 14, 2022

BUY
$2.04 - $3.76 $9,326 - $17,190
4,572 Added 31.07%
19,289 $41,000
Q2 2022

Aug 16, 2022

BUY
$2.04 - $4.68 $30,022 - $68,875
14,717 New
14,717 $42,000
Q1 2022

May 17, 2022

SELL
$3.52 - $5.46 $46,999 - $72,901
-13,352 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$5.1 - $7.0 $68,095 - $93,464
13,352 New
13,352 $69,000
Q3 2021

Nov 16, 2021

SELL
$5.32 - $7.37 $157,408 - $218,063
-29,588 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$4.78 - $7.96 $141,430 - $235,520
29,588 New
29,588 $196,000
Q3 2020

Nov 17, 2020

SELL
$11.64 - $16.3 $158,187 - $221,517
-13,590 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$5.38 - $16.14 $73,114 - $219,342
13,590 New
13,590 $218,000

Others Institutions Holding AUTL

About Autolus Therapeutics plc


  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $208M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.